Anzeige
Mehr »
Donnerstag, 03.09.2026 - Börsentäglich über 12.000 News
Bitcoin: Diese 4 Signale entscheiden über Bullenmarkt oder Falle!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QMBD | ISIN: CA52731E1060 | Ticker-Symbol: 75J
Frankfurt
07.05.26 | 09:10
0,025 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
LEVELJUMP HEALTHCARE CORP Chart 1 Jahr
5-Tage-Chart
LEVELJUMP HEALTHCARE CORP 5-Tage-Chart

Aktueller Chart LEVELJUMP HEALTHCARE Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
LEVELJUMP HEALTHCARE CORP-Investoren interessieren sich auch für diese Wertpapiere
PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsSAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative...
► Artikel lesen
PROCEPT BioRobotics: EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPHUpdated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasiaSAN JOSE, Calif., March 23...
► Artikel lesen
PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation TherapyUK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq:...
► Artikel lesen
Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly HalfFUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting...
► Artikel lesen
Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlowWASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx...
► Artikel lesen
Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceSAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results...
► Artikel lesen
LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year OutlookSCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial...
► Artikel lesen
LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 ResultsSCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results...
► Artikel lesen
S&P Dow Jones Indices: LifeStance Health Group Set to Join S&P SmallCap 600NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective...
► Artikel lesen